Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2007
-
By Jason Derry — When a patent practitioner receives an invention disclosure form, one or more persons will be listed as connected to the invention. It’s easy to get into the practice of simply listing all of those on the invention disclosure form as inventors when filing the application. However, if that list…
-
By Christopher P. Singer — In a November 16, 2007 press release, Pfizer Inc. announced that it will acquire Coley Pharmaceutical Group, Inc. (NASDAQ: COLY). Coley is a biopharmaceutical company that has several research programs which include vaccine adjuvants (VaxImmune®) as well as a class of immunomodulatory drug candidates that are designed to…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Eisai Co., Ltd. et al. v. Teva Pharmaceuticals USA, Inc. et al.2:07-cv-05489; filed November 14, 2007 in the District Court of New…
-
November 13-15, 2007 – Pharma and Biotech Collaborative Agreements (American Conference Institute) – New York, NY*** December 3, 2007 – 18th Annual Conference on U.S. Patent and Trademark Office Law and Practice – PTO Day (Intellectual Property Owners Association and U.S. Patent and Trademark Office) – Washington, D.C. December 13, 2007 – Pharmaceutical and Biotech…
-
By Christopher P. Singer — In a November 9, 2007 press release, the U.S. Patent and Trademark Office announced that the European Patent Office (EPO), the Japan Patent Office (JPO), and the USPTO signed a memorandum of understanding that is designed to address the global workload challenges arising from the growth and complexity…
-
Practising Law Institute (PLI) will be offering a audio-only webcast entitled: "Pharmaceutical and Biotech Patent Law: Recent Developments" on December 13, 2007 from 1:00-2:00 PM (EST). The presentation is part of PLI's One-Hour Patent Hot Topic Briefing series. Speakers David K. Barr and Daniel L. Reisner of Kaye Scholer LLP, co-editors of the PLI treatise…
-
Law Seminars International (LSI) will be holding a conference entitled "Buying, Selling and Licensing Patents: New Case Law, Rules, Legislation and Markets" on January 25-25, 2008 in San Francisco, CA. The conference will provide tips and strategies for managing the patent transaction process and conducting due diligence. In particular, the conference's speakers will offer presentations…
-
By Donald Zuhn — The U.S. Patent and Trademark Office released its FY 2007 Performance and Accountability Report today and announced that the Office had posted record-breaking numbers for 2007. According to the Patent Office, the year-end numbers "reveal historic improvement in the quality of patent and trademark reviews and subsequently the quality…
-
By Donald Zuhn — Last week, CellCyte Genetics announced that it had been granted U.S. Patent No. 7,282,222, which relates to methods for delivering stem cells to a target tissue in a mammal using glycoconjugate to traffic the cells to a desired organ. According to CellCyte’s press release, the Kirkland, Washington based biotech…
-
By Kevin E. Noonan — Continuing its obliquely negative coverage of U.S. Patent law, Peter Lattman of The Wall Street Journal is shocked (shocked!) to find that the University of California is immune from patent infringement suits, despite being an avid participant in obtaining patents on technology developed by its faculty researchers. In…
Patent Docs 